HUP0204547A3 - Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms - Google Patents

Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms

Info

Publication number
HUP0204547A3
HUP0204547A3 HU0204547A HUP0204547A HUP0204547A3 HU P0204547 A3 HUP0204547 A3 HU P0204547A3 HU 0204547 A HU0204547 A HU 0204547A HU P0204547 A HUP0204547 A HU P0204547A HU P0204547 A3 HUP0204547 A3 HU P0204547A3
Authority
HU
Hungary
Prior art keywords
drug
preparing
treatment
indoloquinoxaline
derivatives
Prior art date
Application number
HU0204547A
Other languages
English (en)
Original Assignee
Lundblad Leif J I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundblad Leif J I filed Critical Lundblad Leif J I
Publication of HUP0204547A2 publication Critical patent/HUP0204547A2/hu
Publication of HUP0204547A3 publication Critical patent/HUP0204547A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0204547A 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms HUP0204547A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel
PCT/SE2001/000326 WO2001060371A1 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug

Publications (2)

Publication Number Publication Date
HUP0204547A2 HUP0204547A2 (hu) 2003-04-28
HUP0204547A3 true HUP0204547A3 (en) 2006-01-30

Family

ID=20278504

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204547A HUP0204547A3 (en) 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms

Country Status (14)

Country Link
EP (1) EP1261344B1 (hu)
JP (1) JP2003522792A (hu)
CN (1) CN1192777C (hu)
AT (1) ATE269083T1 (hu)
AU (2) AU2001236266B2 (hu)
CA (1) CA2400236C (hu)
DE (1) DE60103857T2 (hu)
ES (1) ES2222981T3 (hu)
HU (1) HUP0204547A3 (hu)
NO (1) NO323783B1 (hu)
RU (1) RU2266117C2 (hu)
SE (1) SE516067C2 (hu)
WO (1) WO2001060371A1 (hu)
ZA (1) ZA200206733B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner
EP2128160B1 (en) 2008-04-30 2010-07-14 Universität Duisburg-Essen Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner

Also Published As

Publication number Publication date
HUP0204547A2 (hu) 2003-04-28
CN1404393A (zh) 2003-03-19
CA2400236C (en) 2009-09-22
CN1192777C (zh) 2005-03-16
NO20023892D0 (no) 2002-08-16
NO20023892L (no) 2002-08-16
RU2002124771A (ru) 2004-03-10
JP2003522792A (ja) 2003-07-29
SE0000537L (sv) 2001-08-19
ES2222981T3 (es) 2005-02-16
ZA200206733B (en) 2003-08-22
DE60103857D1 (de) 2004-07-22
EP1261344B1 (en) 2004-06-16
CA2400236A1 (en) 2001-08-23
DE60103857T2 (de) 2005-07-14
WO2001060371A1 (en) 2001-08-23
RU2266117C2 (ru) 2005-12-20
SE0000537D0 (sv) 2000-02-18
AU3626601A (en) 2001-08-27
SE516067C2 (sv) 2001-11-12
ATE269083T1 (de) 2004-07-15
NO323783B1 (no) 2007-07-09
EP1261344A1 (en) 2002-12-04
AU2001236266B2 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
SI1158992T1 (en) Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications
HUP0203803A3 (en) Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
EP1311261A4 (en) MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
GB0013378D0 (en) Use of therapeutic benzamide derivatives
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB0013383D0 (en) Therapeutic benzamide derivatives
AU6401101A (en) Use of biguanide derivatives for making a medicine having a wound healing effect
GB0013346D0 (en) Therapeutic benzamide derivatives
HRP20020893A2 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
IL144590A0 (en) A process for the preparation of epothilone derivatives
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL148166A0 (en) Drug for treating fractures
IL150290A (en) Use of mirtazapine for preparation of a medicament for the treatment of sleep disorders
IL147496A0 (en) Preparation of a therapeutic composition
IL156647A0 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
IL150837A (en) Use of fsh for preparing a medicament for treating infertility
IL155431A0 (en) Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
HUP0204547A3 (en) Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
HK1059895A1 (en) Use of pyridoindolone derivatives for preparing anticancer medicines
HUP0600063A2 (en) Novel therapeutic use of a thienylcyclohexylamine derivative
EP1307180A4 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION
PL354872A1 (en) Oral dosage form comprising a salt of morphine or a morphine derivative
AU2001236266A1 (en) Use of a compound for preparing a drug

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees